Improving safety practices for research on dangerous pathogens
Core 2: BSL-3 Practices Core
This study is all about making sure that the lab where scientists work with serious germs, like the coronavirus and AIDS virus, is as safe as possible, so that the researchers can do their important work without risks, which could eventually help patients dealing with infectious diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10910126 on NIH RePORTER |
What this research studies
This research focuses on enhancing safety protocols and practices in a specialized laboratory that handles potentially dangerous pathogens, including the novel coronavirus and AIDS virus. The project aims to create a culture of continuous improvement in safety measures, ensuring that all staff are trained and equipped to conduct research safely. By refining standard operating procedures and providing additional safety personnel, the research seeks to maintain a secure environment for groundbreaking studies. Patients may benefit indirectly through improved research outcomes related to infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by infectious diseases such as COVID-19 or AIDS.
Not a fit: Patients with non-infectious conditions or those not affected by the targeted pathogens may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective treatments for infectious diseases, ultimately benefiting patients affected by these conditions.
How similar studies have performed: Other research in biocontainment and safety practices has shown success in improving research outcomes and safety, indicating that this approach is both tested and valuable.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Alderman, Scott — Duke University
- Study coordinator: Alderman, Scott
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.